Replies to post #143768 on Biotech Values

[DewDiligence]

I'll be first in line to try it.

I’ll probably try the drug too. Third-party payers will probably make us try and fail one or two tiers of the “Z-drugs” before reimbursing for Suvorexant; however, some of these payers define failure as a single night of not working, so the reimbursement workaround ought to be pretty easy.